Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuki Matsui

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Molecular Pharmaceutics|March 10, 2025
Biopharmaceutics Aspects of Sugar Alcohols: Implementation of Patient-Centricity in Pharmaceutical Development and Clinical UseKazuki Matsui
Journal of Cardiovascular Pharmacology|March 21, 2002
Protective effect of Na+ /H+ exchange inhibitor, SM-20550, on impaired mitochondrial respiratory function and mitochondrial Ca2+ overload in ischemic/reperfused rat heartsSetsuko Yamamoto, Kazuki Matsui, Naohito Ohashi
Journal of Pharmaceutical Sciences|May 30, 2020
The Provisional No-Effect Threshold of Sugar Alcohols on Oral Drug Absorption Estimated by Physiologically Based Biopharmaceutics ModelMiki Yamane, Kazuki Matsui, Masahisa Sugihara, et al.
Journal of Cardiovascular Pharmacology|January 16, 2002
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in ratsSetsuko Yamamoto, Kazuki Matsui, Masao Sasabe, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2005
A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivativesHirohiko Hasegawa, Masami Muraoka, Kazuki Matsui, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivativesHirohiko Hasegawa, Masami Muraoka, Kazuki Matsui, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2026
Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based studyYoshinori Takahashi, Kazuki Matsui, Naoya Matsumura, et al.
Nature Protocols|April 5, 2007
Cerasome as an infusible and cell-friendly gene carrier: synthesis of cerasome-forming lipids and transfection using cerasomeYoshihiro Sasaki, Kazuki Matsui, Yasuhiro Aoyama, et al.
Bioorganic & Medicinal Chemistry|May 3, 2005
A novel class of sodium/calcium exchanger inhibitor: design, synthesis, and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivativesHirohiko Hasegawa, Masami Muraoka, Mikiko Ohmori, et al.
Bioconjugate Chemistry|January 19, 2006
RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activityKazuki Matsui, Shohei Horiuchi, Shinsuke Sando, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Molecular Pharmaceutics|March 10, 2025
Biopharmaceutics Aspects of Sugar Alcohols: Implementation of Patient-Centricity in Pharmaceutical Development and Clinical UseKazuki Matsui
Journal of Cardiovascular Pharmacology|March 21, 2002
Protective effect of Na+ /H+ exchange inhibitor, SM-20550, on impaired mitochondrial respiratory function and mitochondrial Ca2+ overload in ischemic/reperfused rat heartsSetsuko Yamamoto, Kazuki Matsui, Naohito Ohashi
Journal of Pharmaceutical Sciences|May 30, 2020
The Provisional No-Effect Threshold of Sugar Alcohols on Oral Drug Absorption Estimated by Physiologically Based Biopharmaceutics ModelMiki Yamane, Kazuki Matsui, Masahisa Sugihara, et al.
Journal of Cardiovascular Pharmacology|January 16, 2002
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in ratsSetsuko Yamamoto, Kazuki Matsui, Masao Sasabe, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2005
A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivativesHirohiko Hasegawa, Masami Muraoka, Kazuki Matsui, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivativesHirohiko Hasegawa, Masami Muraoka, Kazuki Matsui, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2026
Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based studyYoshinori Takahashi, Kazuki Matsui, Naoya Matsumura, et al.
Nature Protocols|April 5, 2007
Cerasome as an infusible and cell-friendly gene carrier: synthesis of cerasome-forming lipids and transfection using cerasomeYoshihiro Sasaki, Kazuki Matsui, Yasuhiro Aoyama, et al.
Bioorganic & Medicinal Chemistry|May 3, 2005
A novel class of sodium/calcium exchanger inhibitor: design, synthesis, and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivativesHirohiko Hasegawa, Masami Muraoka, Mikiko Ohmori, et al.
Bioconjugate Chemistry|January 19, 2006
RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activityKazuki Matsui, Shohei Horiuchi, Shinsuke Sando, et al.
Pageof 5